The patent covers drugs that work by modulating the action of nuclear factor kappa B , or NF-kB , a protein that was discovered in the 1980 's by scientists at Harvard , the Massachusetts Institute of Technology and the Whitehead Institute for Biomedical Research , in Cambridge , Mass . .